Tapewire

Nasdaq · USD

KLRS

Kalaris Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6805
SEC CIK
0001754068
Parsed reports
363

Last 12 months

Inside the activity.

2 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202510
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2021 Filed Mar 4, 2021 01:36 UTC
Vera JuanDirector
SaleCommon Stock 700 $39.53 $27,671.00
Disclosure

SEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 3

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,370,910

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.515 to $39.57. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:36 UTC
Vera JuanDirector
SaleCommon Stock 20,584 $38.73 $797,265.66
Disclosure

SEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 2

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,371,610

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.49 to $39.478. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:36 UTC
Vera JuanDirector
SaleCommon Stock 11,570 $38.28 $442,841.75
Disclosure

SEC source: 0001209191-21-017536 · doc4.xml · nonDerivative · entry 1

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,392,194

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.49 to $38.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:36 UTC
VAN BEEK JEROEN BChief Commercial Officer
SaleCommon Stock 1,600 $39.21 $62,732.96
Disclosure

SEC source: 0001209191-21-017534 · doc4.xml · nonDerivative · entry 2

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 488,230

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.075 to $39.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:36 UTC
VAN BEEK JEROEN BChief Commercial Officer
SaleCommon Stock 4,332 $38.62 $167,300.54
Disclosure

SEC source: 0001209191-21-017534 · doc4.xml · nonDerivative · entry 1

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 489,830

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.06 to $38.945. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:35 UTC
Miller EdwardGeneral Counsel
SaleCommon Stock 2,200 $39.14 $86,107.56
Disclosure

SEC source: 0001209191-21-017529 · doc4.xml · nonDerivative · entry 2

Miller Edward · CIK 0001619252 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 192,811

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.93 to $39.475. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by The Miller Family 2019 Irrevocable Dynasty Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:35 UTC
Miller EdwardGeneral Counsel
SaleCommon Stock 3,800 $38.58 $146,591.84
Disclosure

SEC source: 0001209191-21-017529 · doc4.xml · nonDerivative · entry 1

Miller Edward · CIK 0001619252 · General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 195,011

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 4, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.92 to $38.87. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by The Miller Family 2019 Irrevocable Dynasty Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:34 UTC
Leen Ann M.Chief Scientific Officer
SaleCommon Stock 3,159 $39.18 $123,757.62
Disclosure

SEC source: 0001209191-21-017527 · doc4.xml · nonDerivative · entry 2

Leen Ann M. · CIK 0001763026 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,462,167

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.90 to $39.615. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 01, 2021 Filed Mar 4, 2021 01:34 UTC
Leen Ann M.Chief Scientific Officer
SaleCommon Stock 6,359 $38.46 $244,571.59
Disclosure

SEC source: 0001209191-21-017527 · doc4.xml · nonDerivative · entry 1

Leen Ann M. · CIK 0001763026 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,465,326

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.89 to $38.86. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 23, 2021 Filed Feb 23, 2021 19:42 UTC SaleCommon Stock 200 $41.19 $8,238.00
Disclosure

SEC source: 0001209191-21-013481 · doc4.xml · nonDerivative · entry 8

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 968,619

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F10 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.16 to $41.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 23, 2021 Filed Feb 23, 2021 19:42 UTC SaleCommon Stock 1,801 $40.40 $72,769.04
Disclosure

SEC source: 0001209191-21-013481 · doc4.xml · nonDerivative · entry 7

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 968,819

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.01 to $40.87. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 23, 2021 Filed Feb 23, 2021 19:42 UTC SaleCommon Stock 3,688 $39.46 $145,529.22
Disclosure

SEC source: 0001209191-21-013481 · doc4.xml · nonDerivative · entry 6

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 970,620

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.01 to $39.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 23, 2021 Filed Feb 23, 2021 19:42 UTC SaleCommon Stock 2,800 $38.75 $108,499.44
Disclosure

SEC source: 0001209191-21-013481 · doc4.xml · nonDerivative · entry 5

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 974,308

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.01 to $38.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 23, 2021 Filed Feb 24, 2021 00:44 UTC
Vera JuanDirector
SaleCommon Stock 600 $40.97 $24,582.48
Disclosure

SEC source: 0001209191-21-013486 · doc4.xml · nonDerivative · entry 8

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,403,764

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F9 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.77 to $41.225. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 23, 2021 Filed Feb 24, 2021 00:44 UTC
Vera JuanDirector
SaleCommon Stock 2,300 $40.13 $92,293.94
Disclosure

SEC source: 0001209191-21-013486 · doc4.xml · nonDerivative · entry 7

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,404,364

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.76 to $40.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 23, 2021 Filed Feb 24, 2021 00:44 UTC
Vera JuanDirector
SaleCommon Stock 4,825 $39.11 $188,691.76
Disclosure

SEC source: 0001209191-21-013486 · doc4.xml · nonDerivative · entry 6

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,406,664

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.75 to $39.74. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 23, 2021 Filed Feb 24, 2021 00:44 UTC
Vera JuanDirector
SaleCommon Stock 1,125 $38.33 $43,116.08
Disclosure

SEC source: 0001209191-21-013486 · doc4.xml · nonDerivative · entry 5

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,411,489

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.74 to $38.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 23, 2021 Filed Feb 24, 2021 00:44 UTC
VAN BEEK JEROEN BChief Commercial Officer
SaleCommon Stock 700 $40.32 $28,227.01
Disclosure

SEC source: 0001209191-21-013485 · doc4.xml · nonDerivative · entry 5

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 494,162

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.03 to $40.65. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 23, 2021 Filed Feb 24, 2021 00:44 UTC
VAN BEEK JEROEN BChief Commercial Officer
SaleCommon Stock 1,418 $39.18 $55,556.39
Disclosure

SEC source: 0001209191-21-013485 · doc4.xml · nonDerivative · entry 4

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 494,862

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.75 to $39.65. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 23, 2021 Filed Feb 24, 2021 00:43 UTC
Leen Ann M.Chief Scientific Officer
SaleCommon Stock 800 $40.56 $32,447.52
Disclosure

SEC source: 0001209191-21-013484 · doc4.xml · nonDerivative · entry 6

Leen Ann M. · CIK 0001763026 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,471,685

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020.

F8 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.21 to $41.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 23, 2021 Filed Feb 24, 2021 00:43 UTC
Leen Ann M.Chief Scientific Officer
SaleCommon Stock 1,907 $39.59 $75,497.75
Disclosure

SEC source: 0001209191-21-013484 · doc4.xml · nonDerivative · entry 5

Leen Ann M. · CIK 0001763026 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,472,485

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020.

F7 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.12 to $40.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 23, 2021 Filed Feb 24, 2021 00:43 UTC
Leen Ann M.Chief Scientific Officer
SaleCommon Stock 1,492 $38.83 $57,931.23
Disclosure

SEC source: 0001209191-21-013484 · doc4.xml · nonDerivative · entry 4

Leen Ann M. · CIK 0001763026 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,474,392

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.11 to $39.08. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 22, 2021 Filed Feb 23, 2021 19:42 UTC SaleCommon Stock 310 $43.38 $13,446.41
Disclosure

SEC source: 0001209191-21-013481 · doc4.xml · nonDerivative · entry 4

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 977,108

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.34 to $43.44. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 22, 2021 Filed Feb 23, 2021 19:42 UTC SaleCommon Stock 8,779 $42.80 $375,745.59
Disclosure

SEC source: 0001209191-21-013481 · doc4.xml · nonDerivative · entry 3

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 977,418

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.31 to $43.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 22, 2021 Filed Feb 23, 2021 19:42 UTC SaleCommon Stock 2,334 $41.58 $97,054.49
Disclosure

SEC source: 0001209191-21-013481 · doc4.xml · nonDerivative · entry 2

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 986,197

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.25 to $42.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 00:44 UTC
Vera JuanDirector
SaleCommon Stock 380 $43.40 $16,492.80
Disclosure

SEC source: 0001209191-21-013486 · doc4.xml · nonDerivative · entry 4

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,412,614

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.34 to $43.49. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 00:44 UTC
Vera JuanDirector
SaleCommon Stock 11,050 $42.80 $472,906.85
Disclosure

SEC source: 0001209191-21-013486 · doc4.xml · nonDerivative · entry 3

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,412,994

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.31 to $43.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 00:44 UTC
Vera JuanDirector
SaleCommon Stock 2,891 $41.58 $120,214.72
Disclosure

SEC source: 0001209191-21-013486 · doc4.xml · nonDerivative · entry 2

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,424,044

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.25 to $42.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 00:44 UTC
VAN BEEK JEROEN BChief Commercial Officer
SaleCommon Stock 2,200 $42.82 $94,200.92
Disclosure

SEC source: 0001209191-21-013485 · doc4.xml · nonDerivative · entry 3

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 496,280

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.42 to $43.40. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 00:44 UTC
VAN BEEK JEROEN BChief Commercial Officer
SaleCommon Stock 600 $41.53 $24,916.98
Disclosure

SEC source: 0001209191-21-013485 · doc4.xml · nonDerivative · entry 2

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 498,480

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.27 to $41.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 00:43 UTC
Leen Ann M.Chief Scientific Officer
SaleCommon Stock 4,506 $42.84 $193,034.34
Disclosure

SEC source: 0001209191-21-013484 · doc4.xml · nonDerivative · entry 3

Leen Ann M. · CIK 0001763026 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,475,884

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.38 to $43.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 00:43 UTC
Leen Ann M.Chief Scientific Officer
SaleCommon Stock 1,200 $41.54 $49,846.08
Disclosure

SEC source: 0001209191-21-013484 · doc4.xml · nonDerivative · entry 2

Leen Ann M. · CIK 0001763026 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,480,390

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.28 to $41.83. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 22, 2021 Filed Feb 24, 2021 00:43 UTC
Hagen Brett RChief Accounting Officer
SaleCommon Stock 800 $43.14 $34,509.04
Disclosure

SEC source: 0001209191-21-013482 · doc4.xml · nonDerivative · entry 1

Hagen Brett R · CIK 0001681782 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,765

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 6, 2020

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.00 to $43.39. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 19, 2021 Filed Feb 23, 2021 19:42 UTC SaleCommon Stock 11,990 $41.78 $500,935.01
Disclosure

SEC source: 0001209191-21-013481 · doc4.xml · nonDerivative · entry 1

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 988,531

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.31 to $42.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 19, 2021 Filed Feb 24, 2021 00:44 UTC
Vera JuanDirector
SaleCommon Stock 13,233 $41.79 $553,011.04
Disclosure

SEC source: 0001209191-21-013486 · doc4.xml · nonDerivative · entry 1

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,426,935

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.34 to $42.25. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 19, 2021 Filed Feb 24, 2021 00:44 UTC
VAN BEEK JEROEN BChief Commercial Officer
SaleCommon Stock 4,165 $41.71 $173,719.65
Disclosure

SEC source: 0001209191-21-013485 · doc4.xml · nonDerivative · entry 1

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 499,080

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.41 to $42.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 19, 2021 Filed Feb 24, 2021 00:43 UTC
Leen Ann M.Chief Scientific Officer
SaleCommon Stock 7,541 $41.75 $314,867.67
Disclosure

SEC source: 0001209191-21-013484 · doc4.xml · nonDerivative · entry 1

Leen Ann M. · CIK 0001763026 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,481,590

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.41 to $42.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 08:38 UTC SaleCommon Stock 2,982 $41.49 $123,731.83
Disclosure

SEC source: 0000899243-21-007328 · doc4.xml · nonDerivative · entry 3

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,000,521

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.85 to $41.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 08:38 UTC SaleCommon Stock 2,800 $40.34 $112,950.04
Disclosure

SEC source: 0000899243-21-007328 · doc4.xml · nonDerivative · entry 2

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,003,503

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.85 to $40.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 08:38 UTC SaleCommon Stock 975 $39.68 $38,683.91
Disclosure

SEC source: 0000899243-21-007328 · doc4.xml · nonDerivative · entry 1

Brenner Malcolm · CIK 0001818068 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,006,303

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.83 to $39.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 13:44 UTC
Leen Ann M.Chief Scientific Officer
SaleCommon Stock 1,300 $41.50 $53,950.13
Disclosure

SEC source: 0000899243-21-007336 · doc4.xml · nonDerivative · entry 3

Leen Ann M. · CIK 0001763026 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,489,131

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020.

F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.14 to $41.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 13:44 UTC
Leen Ann M.Chief Scientific Officer
SaleCommon Stock 1,100 $40.44 $44,484.11
Disclosure

SEC source: 0000899243-21-007336 · doc4.xml · nonDerivative · entry 2

Leen Ann M. · CIK 0001763026 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,490,431

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.09 to $40.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 13:44 UTC
Leen Ann M.Chief Scientific Officer
SaleCommon Stock 300 $39.20 $11,760.00
Disclosure

SEC source: 0000899243-21-007336 · doc4.xml · nonDerivative · entry 1

Leen Ann M. · CIK 0001763026 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 2,491,531

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 2, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.94 to $39.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: Shares held by the Ann M. Leen Management Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 13:44 UTC
Hagen Brett RChief Accounting Officer
SaleCommon Stock 541 $40.39 $21,852.67
Disclosure

SEC source: 0000899243-21-007335 · doc4.xml · nonDerivative · entry 2

Hagen Brett R · CIK 0001681782 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,565

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 6, 2020

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.06 to $40.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 13:44 UTC
Hagen Brett RChief Accounting Officer
SaleCommon Stock 200 $39.36 $7,871.00
Disclosure

SEC source: 0000899243-21-007335 · doc4.xml · nonDerivative · entry 1

Hagen Brett R · CIK 0001681782 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,106

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 6, 2020

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.05 to $39.66. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 13:41 UTC
VAN BEEK JEROEN BChief Commercial Officer
SaleCommon Stock 750 $41.50 $31,125.68
Disclosure

SEC source: 0000899243-21-007332 · doc4.xml · nonDerivative · entry 3

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 503,245

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.22 to $41.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 13:41 UTC
VAN BEEK JEROEN BChief Commercial Officer
SaleCommon Stock 800 $40.44 $32,349.44
Disclosure

SEC source: 0000899243-21-007332 · doc4.xml · nonDerivative · entry 2

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 503,995

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.22 to $40.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 13:41 UTC
VAN BEEK JEROEN BChief Commercial Officer
SaleCommon Stock 535 $39.83 $21,311.67
Disclosure

SEC source: 0000899243-21-007332 · doc4.xml · nonDerivative · entry 1

VAN BEEK JEROEN B · CIK 0001743662 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 504,795

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.21 to $40.09. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 13:41 UTC
Vera JuanDirector
SaleCommon Stock 3,710 $41.49 $153,923.08
Disclosure

SEC source: 0000899243-21-007331 · doc4.xml · nonDerivative · entry 3

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,440,168

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.04 to $41.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document
February 18, 2021 Filed Feb 19, 2021 13:41 UTC
Vera JuanDirector
SaleCommon Stock 4,032 $40.44 $163,069.40
Disclosure

SEC source: 0000899243-21-007331 · doc4.xml · nonDerivative · entry 2

Vera Juan · CIK 0001755495 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,443,878

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.93 to $40.90. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.